Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance 23 Apr Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous Healx hires ex-Dyson and GCHQ ace as VP of AI Next Next Near-death experience breathes life into small molecule startup
Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance 23 Apr Written by Alexandra Collingbourne Alexandra Collingbourne
